DA
RVMD icon

Duality Advisers’s Revolution Medicines RVMD Stock Holding History

Duality Advisers’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-25,623
Closed -$826K – 435
2024
Q1 		$826K Buy
+25,623
New +$759K 0.08% 376
2023
Q2 		– Sell
-73,075
Closed -$1.58M – 708
2023
Q1 		$1.58M Buy
+73,075
New +$1.8M 0.18% 216
2022
Q4 		– Sell
-55,772
Closed -$1.1M – 753
2022
Q3 		$1.1M Buy
+55,772
New +$1.23M 0.12% 286

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Duality Advisers's RVMD Position: Q2 2024 in Review

Duality Advisers sold out of Revolution Medicines (RVMD) in Q2 2024, closing a stake of 25,623 shares — an estimated $826K sold.

Duality Advisers first reported a position in RVMD in Q3 2022 and held it in 3 quarters. The position peaked at $1.58M in Q1 2023. 223 funds tracked by Wall St. Rank hold RVMD as of Q2 2024.

  • Duality Advisers reported no remaining Revolution Medicines position as of Q2 2024 after selling out during the quarter.
  • Duality Advisers sold 25,623 Revolution Medicines shares in Q2 2024, an estimated $826K.
  • Duality Advisers first reported a position in Revolution Medicines in Q3 2022 and held it in 3 quarters.
  • Duality Advisers's Revolution Medicines position peaked at $1.58M in Q1 2023.
  • 223 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2024.

Based on Duality Advisers's 13F filing for Q2 2024.